COVID-19. U07.2 COVID-19, virus not identified, COVID-19
Conditions
Interventions
Intervention 1: Intervention group: The product includes herbal syrup (Echinacea, thyme, hyssop, Chebulic Myrobaan), honey and glycyrrhizin drop.Dosage of syrup: every 6 hours
10 cc. Dosage of drop: 20 drops after lunch and dinner. In the intervention group, conventional medicine is used according to the latest protocol of the Ministry of Health at the begining of the study
Sponsors
Dina Pharmed Exir Salamat Co
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Male or female patients 18 years old and older with COVID-19 positive coronavirus 19 PCR Ground glass view at low-dose CT scan Arterial oxygen saturation less than 93% Consciously completed consent form completed by the patient or the patient's supervisor
Exclusion criteria
Exclusion criteria: History of pulmonary malignancy History of asthma or COPD History of Disabling disease or malignancy Liver or kidney disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of cough severity. Timepoint: Day 1 before and at the end of treatment. Method of measurement: Standard cough questionnaire.;Severity of shortness of breath. Timepoint: Day 1 before and at the end of treatment. Method of measurement: Shortness Of Breath With Daily Activity (SOBDA) Questionnaire.;Lung radiologic changes. Timepoint: At beginning and end of the study. Method of measurement: Chest CT scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Hasanzade
Dina Pharmed Exir Salamat Co
Outcome results
None listed